Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...

Ro dives into the link between winter and erectile dysfunction, including reasons why it happens and possible solutions.

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks and strokes in survivors.

Groundbreaking research reveals how a popular diabetes and weight loss medication might offer unexpected help for those dealing with alcohol challenges.

These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...

This can help individuals feel fuller for longer and can promote weight loss. When measured by traditional weight loss ...

Multimorbidity is a condition that is considered a challenge for health systems as the cases significantly rise among the ...

The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...

Study finds that a significant proportion of adults prescribed GLP-1 RAs for weight management discontinue treatment within a ...